Filtros de búsqueda

Lista de obras de Tamás Masszi

A new radiation-free conditioning in bone marrow transplantation and dibromo-mannitol therapy in chronic myeloid leukemia

artículo científico publicado en 1998

A phase 2, randomized, double-blind, placebo-controlled study of siltuximab (anti-IL-6 mAb) and bortezomib versus bortezomib alone in patients with relapsed or refractory multiple myeloma.

artículo científico publicado en 2015

A randomized phase III study of carfilzomib vs low-dose corticosteroids with optional cyclophosphamide in relapsed and refractory multiple myeloma (FOCUS).

artículo científico publicado en 2016

Accelerated clearance alone explains ultra-large multimers in von Willebrand disease Vicenza

artículo científico publicado en 2010

Additional chromosome abnormalities, BCR-ABL tyrosine kinase domain mutations and clinical outcome in Hungarian tyrosine kinase inhibitor-resistant chronic myelogenous leukemia patients

scientific article published on 14 October 2011

Allogeneic bone marrow transplantation for acute leukaemia--IGCI experience. International Group for Chemo-Immunotherapy.

artículo científico publicado en 1996

Allogeneic bone marrow transplantation for acute leukemia in adults

artículo científico publicado en 1998

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia

artículo científico publicado en 2013

An Alu-mediated novel large deletion is the most frequent cause of type 3 von Willebrand disease in Hungary

article

Analyses of Donor-Derived Keratinocytes in Hairy and Nonhairy Skin Biopsies of Female Patients Following Allogeneic Male Bone Marrow Transplantation ⬇️

artículo científico publicado el 17 de marzo de 2011

Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy

artículo científico publicado en 2008

Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leuke

artículo científico publicado en 2018

Apoptosis induction by retinoids in eosinophilic leukemia cells: implication of retinoic acid receptor-alpha signaling in all-trans-retinoic acid hypersensitivity.

artículo científico publicado en 2006

Appearing of bone marrow derived stem cells in healthy and regenerating colonic epithelium

artículo científico publicado en 2009

Autologous stem cell transplantation for malignant lymphomas

artículo científico publicado en 1998

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study.

artículo científico publicado en 2015

Bone marrow transplantation in non-malignant disorders

artículo científico publicado en 1998

Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5-year follow-up.

artículo científico publicado en 2015

Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up

artículo científico publicado en 2014

Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.

artículo científico

CIDP cured by allogeneic hematopoietic stem cell transplantation

scientific article published on 01 August 2007

Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma.

artículo científico publicado en 2016

Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study

artículo científico publicado en 2017

Carfilzomib-lenalidomide-dexamethasone vs lenalidomide-dexamethasone in relapsed multiple myeloma by previous treatment

artículo científico publicado en 2017

Changes in quality of life and disease-related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy

artículo científico publicado en 2015

Characterization and function of histamine receptors in human bone marrow stromal cells.

artículo científico publicado en 2012

Characterization of ABL exon 7 deletion by molecular genetic and bioinformatic methods reveals no association with imatinib resistance in chronic myeloid leukemia.

artículo científico publicado en 2011

Chronic lymphoid leukemia cells are highly sensitive to the combination of prednisolone and daunorubicin, but much less to doxorubicin or epirubicin.

artículo científico publicado en 2010

Chronic myelogenous leukemia: diagnosis and treatment

artículo científico publicado en 2016

Co-occurrence of Myeloproliferative Neoplasms and Solid Tumors Is Attributed to a Synergism Between Cytoreductive Therapy and the Common TERT Polymorphism rs2736100.

artículo científico publicado en 2015

Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population

artículo científico publicado en 2011

Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of th

artículo científico publicado en 2018

Complex molecular genetic algorithm in the diagnosis of myeloproliferative neoplasms

artículo científico publicado en 2014

Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide.

artículo científico publicado en 2017

Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma

artículo científico publicado en 2016

Dasatinib in imatinib-resistant or imatinib-intolerant chronic myeloid leukemia in blast phase after 2 years of follow-up in a phase 3 study: efficacy and tolerability of 140 milligrams once daily and 70 milligrams twice daily

artículo científico publicado en 2010

Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia after failure of first-line imatinib: a randomized phase 2 trial

artículo científico publicado en 2007

Diffusion weighted magnetic resonance imaging demonstrates tumor response following palliative embolization of a recurrent shoulder plasmacytoma

artículo científico publicado en 2014

Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.

artículo científico publicado en 2014

Donor KIR2DS1 reduces the risk of transplant related mortality in HLA-C2 positive young recipients with hematological malignancies treated by myeloablative conditioning

artículo científico publicado en 2019

Drugs, gene transfer, signaling factors: a bench to bedside approach to myocardial stem cell therapy.

artículo científico publicado en 2007

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

artículo científico publicado en 2018

Early Versus Delayed Autologous Stem Cell Transplantation and Interferon Maintenance in Multiple Myeloma: Single-Center Experience of 18 Years.

artículo científico publicado en 2016

Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study).

artículo científico publicado en 2017

Efficacy and safety of ruxolitinib after and versus interferon use in the RESPONSE studies

artículo científico publicado en 2018

Expanding Nilotinib Access in Clinical Trials (ENACT), an open-label multicenter study of oral nilotinib in adult patients with imatinib-resistant or -intolerant chronic myeloid leukemia in accelerated phase or blast crisis.

artículo científico publicado en 2011

Five-year PFS from the AETHERA trial of brentuximab vedotin for Hodgkin lymphoma at high risk of progression or relapse.

artículo científico publicado en 2018

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study.

artículo científico publicado en 2015

HFE C282Y mutation as a genetic modifier influencing disease susceptibility for chronic myeloproliferative disease.

artículo científico publicado en 2009

Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells

artículo científico publicado en 2011

Haematopoietic stem cell transplantation in children in eastern European countries 1985-2004: development, recent activity and role of the EBMT/ESH Outreach Programme

artículo científico publicado en 2008

Health-Related Quality of Life Results From the Open-Label, Randomized, Phase III ASPIRE Trial Evaluating Carfilzomib, Lenalidomide, and Dexamethasone Versus Lenalidomide and Dexamethasone in Patients With Relapsed Multiple Myeloma.

artículo científico publicado en 2016

Health-related quality of life of bosutinib (SKI-606) in imatinib-resistant or imatinib-intolerant chronic phase chronic myeloid leukemia

artículo científico publicado en 2011

High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party

artículo científico publicado en 2017

Identification of prognostic factors for plerixafor-based hematopoietic stem cell mobilization.

artículo científico publicado en 2011

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: A study from the Chronic Malignancies Working Party of the EBMT.

artículo científico publicado en 2018

Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1.

artículo científico publicado en 2017

Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey

artículo científico publicado en 2007

Ixazomib significantly prolongs progression-free survival in high-risk relapsed/refractory myeloma patients.

artículo científico publicado en 2017

JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia.

artículo científico publicado en 2010

Lack of correlation between the number of donor nucleated bone marrow cells or CFU-GM content and the rapidity of engraftment in allogeneic BMT

scientific article published on 01 January 1993

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation

artículo científico publicado en 2008

Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia.

artículo científico publicado en 2016

Lymphocyte subset reconstitution after allogeneic bone marrow transplantation using radiation-free conditioning regimen for patients with chronic granulocytic leukemia

artículo científico publicado el 1 de julio de 1995

Lymphoid aggregates may contribute to the migration and epithelial commitment of bone marrow-derived cells in colonic mucosa.

artículo científico publicado en 2011

Management of adverse events associated with ixazomib plus lenalidomide/dexamethasone in relapsed/refractory multiple myeloma

artículo científico publicado en 2017

Medium-sized FLT3 internal tandem duplications confer worse prognosis than short and long duplications in a non-elderly acute myeloid leukemia cohort.

artículo científico publicado en 2013

Molecular background of a new case of chronic myelogenous leukemia with bcr-abl chimera mRNA lacking the A2 exon

scientific article published on 01 October 1994

Multiple Myeloma of the Central Nervous System: 13 Cases and Review of the Literature.

artículo científico publicado en 2018

NFKB1 -94ins/delATTG polymorphism is a novel prognostic marker in first line-treated multiple myeloma

artículo científico publicado en 2014

Outcome of HLA-matched related allogeneic hematopoietic stem cell transplantation for patients with acute leukemia in first complete remission treated in Eastern European centers. Better results in recent years

artículo científico publicado en 2009

Patient-reported health-related quality of life from the phase III TOURMALINE-MM1 study of ixazomib-lenalidomide-dexamethasone versus placebo-lenalidomide-dexamethasone in relapsed/refractory multiple myeloma

artículo científico publicado en 2018

Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF.

artículo científico publicado en 2014

Persistent long-term human herpesvirus 6 (HHV-6) infection in a patient with langerhans cell histiocytosis.

artículo científico publicado en 2007

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

artículo científico publicado en 2015

Plerixafor for PBSC mobilisation in myeloma patients with advanced renal failure: safety and efficacy data in a series of 21 patients from Europe and the USA ⬇️

artículo científico publicado el 28 de febrero de 2011

Plerixafor to rescue failing chemotherapy-based stem cell mobilization: it's not too late.

artículo científico publicado en 2011

Prognostic factors in light chain amyloidosis

artículo científico publicado en 2015

Proteasome Subunit Beta Type 1 P11A Polymorphism Is a New Prognostic Marker in Multiple Myeloma.

artículo científico publicado en 2017

Quality of life and its socio-demographic and psychological determinants after bone marrow transplantation.

artículo científico publicado en 2013

Quality of life results from a phase 3 study of brentuximab vedotin consolidation following autologous haematopoietic stem cell transplant for persons with Hodgkin lymphoma

artículo científico publicado en 2016

Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms

artículo científico publicado en 2018

Radioguided lymph node biopsy of a chemoresistant lymph node detected on interim FDG PET-CT in Hodgkin lymphoma

artículo científico publicado en 2011

Randomized phase II study of bortezomib, thalidomide, and dexamethasone with or without cyclophosphamide as induction therapy in previously untreated multiple myeloma

artículo científico publicado en 2012

Recipient and donor JAK2 46/1 haplotypes are associated with acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.

artículo científico publicado en 2016

Reduction in the frequency of transplant-related complications in patients with chronic myeloid leukemia undergoing BMT preconditioned with a new, non-myeloablative drug combination

scientific article published on 01 April 1998

Retrospective survey on the prevalence and outcome of prior autoimmune diseases in patients with aplastic anemia reported to the registry of the European group for blood and marrow transplantation

artículo científico publicado en 2010

Revised diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a new classification from the European Society for Blood and Marrow Transplantation.

scientific article published on 16 May 2016

Ruxolitinib versus best available therapy in patients with polycythemia vera: 80-week follow-up from the RESPONSE trial.

artículo científico

Ruxolitinib versus standard therapy for the treatment of polycythemia vera.

artículo científico publicado en 2015

Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.

artículo científico publicado en 2010

Serum beta2-microglobulin measured by immunonephelometry: expression patterns and reference intervals in healthy adults.

artículo científico publicado en 2009

Sex-specific survival difference in association with HLA-DRB1∗04 following allogeneic haematopoietic stem cell transplantation for lymphoid malignancies.

artículo científico publicado en 2017

Sinusoidal obstruction syndrome/veno-occlusive disease: current situation and perspectives-a position statement from the European Society for Blood and Marrow Transplantation (EBMT)

artículo científico publicado en 2015

Skin-homing CD8 T cells preferentially express GPI-anchored peptidase inhibitor 16, an inhibitor of cathepsin K

artículo científico publicado en 2018

Stem cell transplantation in the imatinib era

artículo científico publicado en 2005

Successful combined antifungal salvage therapy with liposomal amphothericin B and caspofungin for invasive Aspergillus flavus infection in a child following allogeneic bone marrow transplantation

scientific article published on 01 January 2006

Successful treatment of renal failure caused by multiple myeloma with HLA-identical living kidney and bone marrow transplantation: a case report.

artículo científico publicado en 2013

Superiority of the triple combination of bortezomib-thalidomide-dexamethasone over the dual combination of thalidomide-dexamethasone in patients with multiple myeloma progressing or relapsing after autologous transplantation: the MMVAR/IFM 2005-04 R

artículo científico publicado en 2012

Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation

scientific article published on 01 October 1999

Ten-Year Remission of Psoriasis after Allogeneic but Not Autologous Bone Marrow Transplantation

artículo científico publicado en 2006

The adverse effect of FOPNL genomic variant is reversed by bortezomib-based treatment protocols in multiple myeloma

artículo científico publicado en 2017

The potential role of HLA-DRB1*11 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy

artículo científico publicado en 2015

The prognostic impact of germline 46/1 haplotype of Janus kinase 2 in cytogenetically normal acute myeloid leukemia.

artículo científico publicado en 2011

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

artículo científico publicado en 2017

VMP (Bortezomib, Melphalan, and Prednisone) is active and well tolerated in newly diagnosed patients with multiple myeloma with moderately impaired renal function, and results in reversal of renal impairment: cohort analysis of the phase III VISTA s

artículo científico publicado en 2009

[Experiences with the first, Hungarian autologous bone marrow cell transplantation in acute myocardial infarction]

scientific article published on 01 January 2006

[Gram-negative bacteremia in neutropenic patients with hematologic disorders. Experiences with prophylactic use of fluoroquinolones]

artículo científico publicado en 2011

[How long does a myeloma patient currently wait for the diagnosis in Hungary?]

scientific article published on 01 September 2014

[Rare case of a pregnancy in a woman with paroxysmal nocturnal hemoglobinuria. Case report]

artículo científico publicado en 2016

[Role of the activating mutation Val617Phe of Janus kinase 2 gene in myeloproliferative diseases and significance of its detection]

scientific article published on 01 February 2007

[Stem cell therapy in cardiovascular diseases]

scientific article published on 01 November 2005

[The bone-marrow transplantation program in Hungary: report from the period 1990-1995]

artículo científico publicado en 1996

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda